Brugada Syndrome Clinical Update

Authors

Rhadames Rojas, New York Medical CollegeFollow
Risheek Kaul
Daniel Frenkel, New York Medical College
Ethan G. Hoch
Sei Iwai, New York Medical CollegeFollow
Jason T. Jacobson, New York Medical CollegeFollow
Wilbert S. Aronow, New York Medical CollegeFollow

Author Type(s)

Faculty

DOI

10.1080/21548331.2021.1906012

Journal Title

Hospital Practice

First Page

255

Last Page

261

Document Type

Article

Publication Date

10-2021

Department

Medicine

Abstract

Brugada syndrome (BrS) was initially described in southeast Asians with a structurally normal heart presenting with polymorphic ventricular tachycardia and fibrillation. This condition is marked by J-point elevation ≥ 2 mm with coved-type ST segment elevation followed by negative T wave inversions in at least one precordial lead (V1 or V2) when other etiologies have been excluded. These changes on electrocardiogram (EKG) can either be spontaneous or manifest after sodium channel blockade. The worldwide prevalence of BrS is about 0.4%; however, it is higher in the Asian population at 0.9%. This article will review the current hypotheses regarding the pathophysiology, spectrum of clinical presentation, strategies for prevention of sudden cardiac death and the treatment for recurrent arrhythmias in BrS.

Recommended Citation

Rojas, R., Kaul, R., Frenkel, D., Hoch, E. G., Iwai, S., Jacobson, J. T., & Aronow, W. S. (2021). Brugada Syndrome Clinical Update. Hospital Practice, 49 (4), 255-261. https://doi.org/10.1080/21548331.2021.1906012